These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19921474)

  • 1. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
    Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
    J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma.
    Buhmeida A; Bendardaf R; Hilska M; Laine J; Collan Y; Laato M; Syrjänen K; Pyrhönen S
    Ann Oncol; 2009 Jul; 20(7):1230-5. PubMed ID: 19276398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Cancer Invest; 2010 Jan; 28(1):38-43. PubMed ID: 20001295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.
    Al-Maghrabi J; Al-Ahwal M; Buhmeida A; Syrjänen K; Sibyani A; Emam E; Ghanim A; Al-Qahtani M
    J Gastrointest Cancer; 2012 Jun; 43(2):279-87. PubMed ID: 21637966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
    Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A
    Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.
    Elzagheid A; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
    APMIS; 2012 Jul; 120(7):539-48. PubMed ID: 22716209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
    Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
    Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
    Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
    Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
    Yang B; Su K; Gao J; Rao Z
    Asian Pac J Cancer Prev; 2012; 13(3):1049-52. PubMed ID: 22631636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.
    Elzagheid A; Emaetig F; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
    Tumour Biol; 2013 Apr; 34(2):621-8. PubMed ID: 23179399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
    Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
    World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
    Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.
    Al-Maghrabi J; Buhmeida A; Emam E; Syrjänen K; Sibiany A; Al-Qahtani M; Al-Ahwal M
    World J Gastroenterol; 2012 Apr; 18(15):1793-9. PubMed ID: 22553404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
    Yang B; Gao J; Rao Z; Shen Q
    Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer.
    Fan XJ; Wan XB; Fu XH; Wu PH; Chen DK; Wang PN; Jiang L; Wang DH; Chen ZT; Huang Y; Wang JP; Wang L
    Tumour Biol; 2014 Oct; 35(10):10487-95. PubMed ID: 25056534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
    Wang Y; Wei Y; Huang J; Li X; You D; Wang L; Ma X
    BMC Cancer; 2024 Aug; 24(1):1065. PubMed ID: 39210344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.